ExodusPoint Capital Management, LP - 10 Nov 2025 SCHEDULE 13G Report for Keros Therapeutics, Inc. Common Stock, $0.0001 par value per share (KROS)

Filing Manager
ExodusPoint Capital Management, LP
Reporting Manager
ExodusPoint Capital Management, LP
Security
Keros Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol
KROS
Shares outstanding
30,284,111 shares
Disclosed Ownership
1,907,899 shares
Ownership
6.3%
Form type
SCHEDULE 13G
Filing time
18 Nov 2025, 16:07:33 UTC
Date of event
10 Nov 2025
Next filing
17 Feb 2026
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ExodusPoint Capital Management, LP 6.3% 1,907,899 0 1,907,899 /s/ Timothy Cruise Timothy Cruise, Authorized Signatory
ExodusPoint Capital Partners GP, LLC 6.3% 1,907,899 0 1,907,899 /s/ Timothy Cruise Timothy Cruise, Authorized Signatory
Michael Gelband 6.3% 1,907,899 0 1,907,899 /s/ Michael Gelband Michael Gelband